The vaccine's success isn't solely due to mRNA. It 'trains' the immune system to spot cancer cells, while a companion drug (a checkpoint inhibitor) simultaneously disables the tumor's ability to suppress that immune response. This dual approach is the real breakthrough.
For personalized cancer vaccines, the speed of development from biopsy to injection is critical. Traditional methods are too slow. mRNA technology enables custom vaccine creation in just weeks, making a rapid, tailored response to a patient's specific tumor possible for the first time.
The revolutionary personalized mRNA therapy is extremely expensive to produce and is administered alongside an already costly drug. Even if proven effective, its high price tag could make it inaccessible for widespread use, creating an 'incredibly clever' therapy that is not widely available.
In response to unpredictable US tariffs, Canada is fast-tracking infrastructure projects, like new pipelines to its west coast. This strategic shift aims to reduce its heavy reliance on the US market (where 90% of its oil was sent) and open up direct access to Asian and European buyers.
Early in her career, Dolly Parton rejected Elvis Presley's request to cover "I Will Always Love You" because his team demanded 50% of the publishing rights. This decision to retain full ownership of her intellectual property, while difficult at the time, ultimately earned her millions.